In Paice LLC, The Abell Foundation, Inc., v. Ford Motor Company, Appeal No. 2017-1406 (Fed. Cir. Feb. 1, 2018), the Federal Circuit reversed a PTAB
Given the popularity of AIA post-grant proceedings, many patent litigators have been newly drawn into proceedings before the Patent Trial and Appeal
In a highly anticipated decision, a divided panel of the U.S. Court of Appeals for the Second Circuit ruled in Marblegate Asset Mgmt., LLC v. Educ
The United States Court of Appeals for the Second Circuit recently held that, for purposes of diversity jurisdiction, a national bank is only a
A federal district court in Illinois ruled that a plan’s forum selection was unenforceable because it conflicts with ERISA’s public policy of
Last week, the Supreme Court declined to make any changes to IPR procedure in its opinion in Cuozzo Speed Technologies, LLC v. Lee, 579 U.S. ___
The U.S. Court of Appeals for the Fifth Circuit held on June 23, 2014 that an oversecured lender's legal fees were subject to the bankruptcy court's
The issue of whether a state law “fraud-on-the-FDA” claim is preempted by federal law will find its way back to the Sixth Circuit in the matter of Tiefenthal v. Genentech, Inc. et seq., in which the plaintiff seeks review of a decision from the District Court for the Western District of Michigan holding that the “fraud-on-the-FDA” exception to the immunity afforded pharmaceutical manufacturers under Michigan’s products liability statute (Mich. Comp. Laws 600.2946) is impliedly preempted by the Food, Drug, and Cosmetic Act, 21 U.S.C. 301 et seq.
A new decision by the Ninth Circuit Court of Appeals highlights the risks brand owners face when adopting a new trademark that also happens to correspond to an Internet domain name already registered to someone else.
The failure to timely file a proof of claim can have significant ramifications on a creditor’s right.